Akari Therapeutics Plc’s ( NASDAQ:AKTX ) latest earnings announcement in December 2017 confirmed company earnings became less negative compared to the previous year’s level as a result of recent tailwinds Below, I’ve laid out key growth figures on how market analysts view Akari Therapeutics’s earnings growth outlook over the next few years and whether the future looks brighter. I will be using net income excluding extraordinary items in order to exclude one-off volatility which I am not interested in. See our latest analysis for Akari Therapeutics
Analysts’ expectations for next year seems relatively subdued, with earnings continuing to flop around in the negative territory, arriving at -US$31.74M in 2019. Furthermore, earnings should fall further and stay relatively flat over the next few years, reaching -US$39.46M in 2021.
While it’s informative knowing the growth each year relative to today’s value, it may be more beneficial to evaluate the rate at which the company is rising or falling every year, on average. The pro of this method is that we can get a bigger picture of the direction of Akari Therapeutics’s earnings trajectory over the long run, irrespective of near term fluctuations, fluctuate up and down. To compute this rate, I’ve inserted a line of best fit through analyst consensus of forecasted earnings. The slope of this line is the rate of earnings growth, which in this case is 7.58%. This means, we can expect Akari Therapeutics will grow its earnings by 7.58% every year for the next few years.
For Akari Therapeutics, there are three fundamental aspects you should further examine:
- Financial Health : Does it have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.
- Future Earnings : How does AKTX’s growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart .
- Other High-Growth Alternatives : Are there other high-growth stocks you could be holding instead of AKTX? Explore our interactive list of stocks with large growth potential to get an idea of what else is out there you may be missing!
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned.